If Sudarshan Chemical Industries sat on your watchlist instead of your demat account this year, the outcome may feel expensive. For Sudarshan Chemical Industries shareholders, the return from the start of the year was 23.5%, including dividends. The move invites a blunt question. Back on 1 January 2026, what clues in the debate over potential P/E and margin changes, tied to post acquisition integration and board decisions on cost and capacity, could reasonably have signalled that kind of outcome?
Sudarshan Chemical Industries has already moved. See which of 198 high quality undervalued stocks still trade below our estimates.
What The Market Was Arguing About In Sudarshan Chemical Industries
The shares cost ₹943 at the start of the period, and investors in Sudarshan Chemical Industries were pulled between two very different stories.
The bullish camp saw a fair value of ₹1,376, a notional price based on assumptions that revenue could grow 51.3% and profit margins might reach 5.0%, with a future P/E of 34.0x over three years.
The cautious view used a fair value of ₹835, again an implied number, and focused on the possibility that tighter regulation and high working capital needs could keep cash flows and profitability under pressure.
What The Results Changed For Sudarshan Chemical Industries
The clearest test came from reported numbers. Sudarshan Chemical Industries recorded revenue of ₹23,874m in Q2 2026 and ₹27,426m in Q2 2027, while net income moved from ₹117m to ₹276m and net margin shifted from 0.5% to 1.0%. Profitability improved but stayed low, so the results supported parts of the optimistic case yet still left the cautious thesis in play.
The live assumption was margin repair. For another stock with a similar story, it can be helpful to track net income and margin together against the original P/E argument, rather than treating revenue alone as confirmation.
What Today’s Sudarshan Chemical Industries Price Already Assumes
Sudarshan Chemical Industries now trades at ₹1,159, up 23.5% from the start of the year, and the bearish analyst Narrative on Simply Wall St places its Fair Value below that level.
That Narrative argues you need confidence that integration, cost work and cash conversion keep delivering, because a buyer today is effectively assuming sustained EBITDA strength and tighter working capital.
“The numbers imply that the share price already reflects a fairly valued, bullish scenario in which Sudarshan Chemical Industries executes on its global pigment platform, cost programs, and EBITDA targets without major setbacks.”
